|
MAY INCREASE DROWSINESS EFFECT
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
NEUROMUSCULAR BLOCKING ACTION OF TUBOCURARINE LIKE DRUGS IS ENHANCED
|
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
ALCOHOL ACCELERATE THE METABOLISM OF THE DRUG BY LIVER BY INDUCING HEPATIC ENZYMES
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY CAUSE SEVERE CARDIAC ARRHYTHMIAS
|
CALCIUM CHANNEL BLOCKERS POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY, AND AUTOMATICITY AS WELL AS VASCULAR DILATION ASSOCIATED WITH ANESTHETICS
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
OPIOID ANALGESICS RESPIRATORY DEPRESSANT EFFECT IS ENHANCED
|
DOXAPRAM THERAPY SHOUL BE DELAYED FOR ATLEAST 10 MTS FOLLOWING DISCONTINUANCE OF ANAESTHESIA WITH HALOTHANE, CYCLOPROPANE,ENFLURANE WHICH ARE KNOWN TO SENSITIZE MYOCARDIUM TO CATECHOLAMINES,SINCE AN INCREASE IN EPINEPHRINE RELEASE HAS BEEN NOTED
|
CONCOMITANT USE MAY MAKE PATIENT MORE SENSITIVE TO MYOCARDIAL DEPRESSANT AND CONDUCTION EFFECTS OF HALOGENATED INHALATIONAL ANESTHETICS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|
CALCIUM CHANNEL BLOCKERS MAY POTENTIATE THE DEPRESSION OF CARDIAC CONTRACTILITY, CONDUCTIVITY & AUTOMATICITY AS WELL AS VASCULAR DILATATION ASSOCIATED WITH ANAESTHETICS
|